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Background: Prolongation of the QT interval of the electrocardiogram (ECG), underlain
by prolongation of the action potential duration (APD) at the cellular level, is linked
to increased vulnerability to cardiac arrhythmia. Pharmacological management of
arrhythmia associated with QT prolongation is typically achieved through attempting to
restore APD to control ranges, reversing the enhanced vulnerability to Ca2+-dependent
afterdepolarisations (arrhythmia triggers) and increased transmural dispersion of
repolarisation (arrhythmia substrate) associated with APD prolongation. However, such
pharmacological modulation has been demonstrated to have limited effectiveness.
Understanding the integrative functional impact of pharmacological modulation requires
simultaneous investigation of both the trigger and substrate.
Methods: We implemented a multi-scale (cell and tissue) in silico approach using a
model of the human ventricular action potential, integrated with a model of stochastic
3D spatiotemporal Ca2+ dynamics, and parameter modification to mimic prolonged
QT conditions. We used these models to examine the efficacy of the hERG activator
MC-II-157c in restoring APD to control ranges, examined its effects on arrhythmia triggers
and substrates, and the interaction of these arrhythmia triggers and substrates.
Results: QT prolongation conditions promoted the development of spontaneous
release events underlying afterdepolarisations during rapid pacing. MC-II-157c
applied to prolonged QT conditions shortened the APD, inhibited the development
of afterdepolarisations and reduced the probability of afterdepolarisations
manifesting as triggered activity in single cells. In tissue, QT prolongation resulted
in an increased transmural dispersion of repolarisation, which manifested as
an increased vulnerable window for uni-directional conduction block. In some
cases, MC-II-157c further increased the vulnerable window through its effects
on INa. The combination of stochastic release event modulation and transmural
dispersion of repolarisation modulation by MC-II-157c resulted in an integrative
behavior wherein the arrhythmia trigger is reduced but the arrhythmia substrate
is increased, leading to variable and non-linear overall vulnerability to arrhythmia.
Colman et al. Arrhythmia Modulation: Trigger vs. Substrate
Conclusion: The relative balance of reduced trigger and increased substrate underlies
a multi-dimensional role of MC-II-157c in modulation of cardiac arrhythmia vulnerability
associated with prolonged QT interval.
Keywords: QT interval, action potential duration, arrhythmia trigger, arrhythmia substrate, hERG activators,
computational modeling
INTRODUCTION
Conditions in which the QT interval of the electrocardiogram
(ECG) is prolonged, such as heart failure (Hart, 1994) and
inherited or acquired long QT syndromes (LQTS) (Schwartz
et al., 2012), are associated with an increased risk of ventricular
arrhythmias (Tomaselli and Zipes, 2004; Moss and Kass,
2005). The prolonged QT interval reflects prolongation of the
ventricular cellular action potential duration (APD), which can
result in arrhythmias through an increase in cell-level arrhythmia
triggers and/or modification of tissue-level arrhythmia substrates
(Kalin et al., 2010; Benson et al., 2011a; Tse, 2016).
Cell-level triggers arise because delayed ventricular
repolarisation modifies membrane and subcellular Ca2+
handling (Clusin, 2003; Neˇmec et al., 2016), leading to
either re-activation of the L-type Ca2+ current and early
afterdepolarisations (Lankipalli et al., 2005), or Ca2+ overload
of the sarcoplasmic reticulum (SR), causing spontaneous SR
Ca2+ release events and delayed-afterdepolarisations through
activation of the forward-mode Na+-Ca2+ exchange current
(INaCa), which in turn can result in triggered activity if the
delayed afterdepolarisation is of sufficient magnitude (Janse,
2004). Cardiomyocytes typically exhibit a threshold dependence
of the occurrence of spontaneous release events as a function of
SR Ca2+ load, wherein the probability of a spontaneous release
event rapidly rises from 0 to 1 within a critical region of SR
Ca2+ (Venetucci et al., 2007; Campos et al., 2015). Although
originating at the cell level, triggers need to be coordinated at
the tissue level in order to develop into arrhythmias: a critical
compact region of tissue simultaneously exhibiting triggered
behavior is required to initiate propagation of the trigger (Noble,
1972; Clayton et al., 2011; Bezekci et al., 2015; Campos et al.,
2015).
An increase in the tissue-level substrates for arrhythmias
(that is, the necessary conditions for triggered activity to
propagate and develop into arrhythmias) arise because APD
prolongation is rarely homogenous in and between the different
regions of the ventricles (e.g., transmurally, or from base
to apex) (Antzelevitch, 2005; Glukhov et al., 2010). This
heterogeneous APD prolongation increases the spatial dispersion
of repolarisation, potentially leading to regions of recovered
(i.e., excitable) tissue partially bordered by still refractory (i.e.,
unexcitable) tissue. A propagating trigger event occurring in
such a location can be partially blocked by the refractory tissue,
leading to re-entrant arrhythmias (Pandit and Jalife, 2013). The
spatiotemporal region where such partial conduction block could
occur is termed the “vulnerable window” (VW) (Starmer et al.,
1993; Shaw and Rudy, 1995; Benson et al., 2008, 2011a). It follows
that heterogeneous APD prolongation increases not only the
spatial dispersion of repolarisation, but also the VW, i.e., the
arrhythmia substrate.
The interaction of triggers and substrates determines the
initiation of arrhythmia: an arrhythmia cannot be initiated
without both a suitably-sized and -timed trigger and the
necessary substrate to allow that trigger to propagate in a re-
entrant manner (Kalin et al., 2010). Arrhythmias, therefore, are
not cellular events, but tissue-level events.
Management of arrhythmias associated with QT prolongation
can be achieved by attempting to restore the ventricular APD
to control ranges (Nachimuthu et al., 2012), thus reversing the
increases in arrhythmogenic triggers and substrates associated
with APD prolongation. One such strategy is the use of
human ether-a-go-go-related-gene channel (hERG) activators
that enhance the repolarising rapid delayed rectifier K+ current
(IKr), thus reducing the APD (Grunnet et al., 2008; Wu and
Sanguinetti, 2016). However, many anti-arrhythmic drugs have
pro-arrhythmic effects (Kumar and Zimetbaum, 2013); such
drugs can shorten the action potential and the QT interval
(reducing arrhythmias associated with a prolonged QT interval),
but they may have additional and unintended effects that
increase (rather than reduce) the propensity for arrhythmias
under certain conditions. For example, we have shown in a
previous experimental and computational study that the hERG
activator NS1643, one of the most effective and best characterized
hERG activators (Hansen et al., 2006), successfully restores APD
toward healthy durations and reduces arrhythmia triggers, but
is associated with an increase in the VW, i.e., the substrate
for arrhythmias, due to effects on the post-repolarisation
refractory period (Peitersen et al., 2008). Furthermore, while low
concentrations of NS1643 activates IKr and shortens APD, it has
been shown that higher concentrations of NS1643 blocks (rather
than activates) IKr (Bilet and Bauer, 2012).
The potentially pro-arrhythmic effects of hERG activators,
such as NS1643 has prompted the search for novel hERG
activators that do not display these effects. One recently-
identified compound is MC-II-157c, an NS1643 analog. MC-
II-157c activates IKr at low concentrations and, unlike NS1643,
it continues to activate IKr at high concentrations; it may also
block the sodium current (INa) (Guo et al., 2014). However, it
remains unknown how the IKr activation and INa block seen with
this new compound affect arrhythmia triggers and substrates,
and importantly, how these (increased or decreased) triggers and
substrates interact to induce arrhythmias (if at all).
Computational models provide powerful research tools to
understand the intricacies of arrhythmia trigger and substrate
interaction, as they allow us tomodify parameters under precisely
controlled conditions and quantify the resultant tissue-level
arrhythmic behavior, and can predict how these arrhythmias
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will manifest in a clinical setting (e.g., changes to the ECG).
We therefore used a computational approach to quantify the
interaction of pharmacologically-modified arrhythmia trigger
and substrate, using the novel hERG activator MC-II-157c as an
example.
We wanted to quantify the modified triggers and substrate
that result from MC-II-157c ion channel actions. To this end,
we use detailed single cell and tissue level models to study
the effect of QT prolongation and its modulation by MC-II-
157c on: (i) APD heterogeneity in isolated cells; (ii) SR Ca2+
loading and subsequent spontaneous SR Ca2+ release events; (iii)
the probability of spontaneous SR Ca2+ release manifesting as
triggered action potentials in single cell and ectopic activity in
tissue; and (iv) the vulnerability to the initiation of re-entrant like
conduction patterns.
METHODS
We implemented a multi-scale in silico approach to study
the interactions between arrhythmia trigger and substrate in
conditions associated with prolonged QT intervals, and their
modulation by the hERG activator MC-II-157c.
Isolated Cell Models – Intracellular Ca2+
Handling
In order to simulate triggered and ectopic activity underlain by
spontaneous Ca2+ release events, a spatial model of intracellular
Ca2+ handling which explicitly accounts for stochastic state
transitions and spatial coupling is required. We therefore
implemented an efficient, idealized reduction of a previously
developed and validated general model of spatio-temporal Ca2+
handling with realistic structure (Colman et al., 2017), using a
similar approach implemented by other groups (e.g., Restrepo
et al., 2008). Briefly, 15 × 20 × 65 spatially-discrete individual
calcium release units (CRUs) were modeled throughout the
geometry of the cell (Figure 1). Each CRU comprises of
five compartments with associated Ca2+ concentrations: the
intracellular spaces of the dyadic cleft space ([Ca2+]ds), subspace
([Ca2+]SS) and bulk-cytosolic space ([Ca
2+]i), and the network
and junctional SR ([Ca2+]nSR, ([Ca
2+]jSR). The bulk cytosol,
subspace and network SR are diffusively coupled to neighboring
CRUs; the dyadic cleft space and junctional SR are not
spatially coupled to neighbors. The fundamental model equations
describing this system are:
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where vx is the volume of compartment x, βx is an instantaneous
buffering term, and ϕx is the reaction term. Stochastic dynamics
aremodeled for the RyRs and LTCCs, which are part of the dyadic
cleft space reaction term. All parameters and reaction terms are
given in the Supplementary Material.
Isolated Cell Models - Action Potential
Model
Ion currents were described by a simplified version of the
O’Hara-Rudy dynamic (ORd) human ventricular cell model
(O’Hara et al., 2011), wherein the major currents only (INa, IKr,
IKs, IK1, Ito, INaK) were included, without the further details of
phosphorylation included in the original study; Ca2+ currents
(ICaL, INaCa, ICap, ICab) are described by the Ca
2+ handling
model. These simplifications were implemented to improve
computational efficiency and for integration with the general
stochastic Ca2+ handling model described above. The model
provides specific formulations to describe the heterogeneity
in ionic currents of the transmural cell types (endocardial,
midmyocardial, and epicardial) found in the left ventricular free
wall of the human heart (see O’Hara et al., 2011) for details.
This integrated stochastic framework captures spontaneous
Ca2+ release events that could lead to triggered activity (see
details in Simulating Spontaneous Release Events in Tissue
Models below). Default model action potentials and cytosolic
Ca2+ transients, for the three transmural cell types of the
simplified ORd model with stochastic Ca2+ handling, are shown
in Figure 1B. The updated cell model exhibits action potential
and Ca2+ transient properties similar to the original cell model
and within the range of experimental data presented in the
original study (O’Hara et al., 2011): APD = 272–360 ms and
intracellular Ca2+ transient magnitude of ∼0.6µM for the three
cell-types during control pacing; note that the present study does
not consider heterogeneity in the intracellular Ca2+ handling
system and thus the Ca2+ transient is more homogeneous
between the cell types than in the original study (see Limitations).
The model is therefore considered suitable for the mechanistic
study undertaken.
Prolonged QT and Pharmacological
Modulation
We were interested in general cases of QT prolongation rather
than modeling the kinetics of very specific conditions, while still
making our results broadly applicable to clinical conditions, such
as LQTS. We therefore simulated QT interval prolongation (i.e.,
prolongation of the ventricular APD) in one of three ways: (i)
downregulation of the slow delayed rectifier K+ current (IKs)
maximal conductance by 50%, similar to LQTS1, which we
term “prolonged QT variant a” (PQTa) in the remainder of the
manuscript; (ii) downregulation of IKr maximal conductance by
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FIGURE 1 | Model schematic. (A) Schematic structure of the spatio-temporal Ca2+ handling model with the compartments comprising a single CRU, and coupling
between compartments, illustrated. DS, dyadic cleft space; SS, subspace; CTYO, bulk intracellular space; JSR, junctional SR; NSR, network SR. NX, 15; NY, 20; NZ,
65. (B) Action potentials (upper) and Ca2+ transients (lower) during control pacing (BCL = 1, 000 ms) for the three cell types (ENDO, Endocardium; M,
Midmyocardium; EPI, Epicardium).
50% (PQTb), similar to LQTS2; and (iii) upregulation of ICa,L
maximal conductance by 50% (PQTc), similar to LQT8 (Bohnen
et al., 2017).
Effects of 10µM of the hERG activator MC-II-157c on IKr
were modeled by modifying the IKr formulation according to
experimental data (Guo et al., 2014): maximal conductance
was decreased by 12%, activation was shifted by −14 mV and
inactivation by +14 mV, and deactivation kinetics were slowed
3.3-fold (note that, although the maximal conductance of IKr is
reduced by MC-II-157c, its kinetic effects enhance the activity
of the current; see The hERG Activator MC-II-157c Partially or
Fully Reverses APD Prolongation Heterogeneously). Effects of
MC-II-157c on blocking INa (which are not as well characterized
as its effects on IKr; Guo et al., 2014) were simulated by reducing
the maximal conductance of INa by 0, 40, and 80%.
Tissue Models
We used a 20mm 1D virtual tissue strand (Kléber and Rudy,
2004) for quantifying transmural propagation and vulnerability,
with equal spatial distributions of endocardial, midmyocardial
and epicardial cells. A 20 × 40mm 2D tissue sheet (Clayton
et al., 2011) was used for simulations examining propagation
of triggered activity, with equal distributions of endocardial,
midmyocardial and epicardial tissue in the x direction. For
examining intramural propagation and ectopic activity in 3D,
we used an anatomically detailed 3D ventricular wedge model,
obtained by diffusion tensor MRI, and used equal proportions
of endocardial, midmyocardial and epicardial tissue in the
transmural direction (see Benson et al., 2007, 2011b; Walton
et al., 2013 for details).
All tissues were isotropic, i.e., conduction velocity was set to be
equal in all directions: We used an electrical diffusion coefficient
of D = 0.048 mm2ms−1, to give a conduction time along the 1D
strand (i.e., a transmural activation time) of 40 ms (cf. Glukhov
et al., 2010), and a plane wave conduction velocity of 0.5m.s−1 in
all tissues. The body surface potential was computed by placing
the ventricular wedge model in a human torso mesh; the forward
problem was solved by a boundary element method, as has been
described in previous studies (Perez Alday et al., 2015, 2016,
2017). ECGs were derived from the body surface potential by
selecting elements of the torso mesh which correspond to the
ECG electrodes.
Simulating Spontaneous Release Events in
Tissue Models
Performing tissue level simulations using the fully detailed
spatial Ca2+ handling model to describe individual cells is
computationally intractable due to the large number of equations
that need to be solved in such situations. Furthermore, the
focus of this study was not to dissect the mechanisms of
spontaneous Ca2+ release in single cell, but rather to understand
the considerations determining the manifestation of sub-cellular
Ca2+ release as triggered action potentials and propagating
electrical excitation in the presence of prolonged APD and its
pharmacological modulation.
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We therefore implemented a “non-spatial” simplification of
the Ca2+ handling model (described in Isolated Cell Models–
Intracellular Ca2+ Handling, above) for use in tissue-level
simulations, to capture spontaneous Ca2+ release events at
significantly reduced computational cost and with complete
controllability. The non-spatial model consists of a single
CRU (with RyR and LTCC dynamics solved deterministically)
with additional analytical functions which describe the RyR
waveform associated with whole-cell spontaneous release
events, derived from analysis of the fully detailed spatial
cell model, similar to the approach used in Campos et al.
(2015) and Colman et al. (2015). For a simple transient-
spike morphology (Figure 2) this function has the form:
NRyR_O =
NRyR_peak(
1+ e−(t−(ti+0.5tup))/(0.1689tup+0.00255)
) (
1+ e−
(
t−
(
ti+tup+0.5tdecay
))
/
(
0.1689tdecay+0.00255
))
where ti is the initiation time of the spontaneous release and
tup, tdecay and NRyR_peak describe the shape of the waveform
and are all determined from the duration (Figures 2, 3 and
described below). The function for the plateau-like waveform
(corresponding to durations longer than 250 ms) is derived from
the same parameters (note the peak time, tp, is ti+tup):
NRyR_O =
NRyR_plateau(
1+ e−(t−(ti+17.5))/5.946
) (
1+ e
(
t−
(
tf−17.5
))
/5.946
)
+
NRyR_peak − NRyR_plateau(
1+ e−
(
t−
(
tp−17.5
))
/5.946
) (
1+ e
(
t−
(
tp+17.5
))
/5.946
)
Thus, the waveform is completely described by the initiation
time and the duration. The stochastic nature of spontaneous
Ca2+ release is captured by randomly selecting these parameters
from functions describing their physiological distributions.
The distributions describing initiation time of whole-cell
spontaneous release events in the spatial cell model are typically
skewed (Figure 3Aa) and well approximated by two sigmoidal
functions, split around the cumulative probability of 0.25
(corresponding to a specific initiation time, ti_sep; Figure 3Ab).
The initiation time can therefore be determined by passing
a random number into the inverse of the two sigmoidal
functions:
ti =
{
−kF1 ln
(
0.5
rand
− 1
)
+ tisep , rand < 0.25
−kF2 ln
(
1.5
rand + 0.5
− 1
)
+ tisep , rand ≥ 0.25
where the gradient parameters of the two sigmoidal functions
(kF1, kF2) and the ti at the cumulative probability of 0.25, ti_sep,
completely control the resulting distribution. The duration, D, of
the RyR waveform can be determined from distributions in an
analogous manner:
D =
{
k1_MD ln
[
1/
(
rand − 1
)]
+MD, rand < 0.5
k2_MD ln
[
1/
(
rand − 1
)]
+MD, rand ≥ 0.5
where MD refers to the median and k1_MD and k2_MD are
functions of the median (in conditions where longer waveforms
are observed, the variability in waveform duration between
simulations is larger; Figure 3Ba–c):
k1_MD = 0.1366MD− 7.98
k2_MD = 0.12MD− 3.265
FIGURE 2 | Spontaneous excitation RyR waveforms and parameters. (A) Four examples of RyR waveforms associated with whole-cell spontaneous release events in
the spatial cell model. Parameters describing the shape of the waveform are labeled. (B) Analytical waveforms approximating those in (A) using the input parameters
listed.
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FIGURE 3 | Derivation of the RyR waveform parameters. (A) Initiation time distributions: (a) is an example distribution produced by the spatial cell model; (b) is the
cumulative frequency of the distribution (purple dots) and two sigmoidal functions (red and green lines) which approximate it–the distribution itself is shown for
reference (blue shading); (c) cumulative frequencies of the three distributions used in this study (ti distribution widths of 350 ms–blue; 550 ms–red; 1,000 ms–purple),
with the histogram corresponding to the red distribution shown for reference. (B) Duration distributions: (a) scatter-plot of the durations associated with multiple
simulations under different conditions (colors), plotted against the median of each distribution, which is also shown as the red diamonds for reference; (b,c) correlation
of the gradient parameters of sigmoidal functions describing the distribution either side of the median with the median value; (d) four duration distributions used in the
present study (Median Duration = 150 ms–red; 200 ms–blue; 250 ms–purple; 300 ms–green). (C) Other parameters correlate with the duration–time to peak (tup, a)
and the waveform peak (NRyR_peak , b).
Thus, the distribution is entirely described by themedian. Finally,
tup and NRyR_peak can be determined from the given duration
(Figure 3C):
tup = 24+ rand(D− 52)
NRyR_peak =
{
MRYR− rand(159.59(D−1.327 − D−1.4)), rand < 0.5
MRYR− (1− rand)(159.59
(
(D+ 30)−1.15 + D−1.327
)
+ 0.08), rand ≥ 0.5
WhereMRYR refers to the median and is given by:
MRYR = 159.59D−1.327 + 0.028
And if duration > 250 ms, it is also necessary to compute
NRyR_plateau:
NRyR_plateau = 31.09(0.01D)
−7.39
+(rand − 0.5)(−5× 10−4D_0.0275)+ 0.34
These formulations therefore allow complete control over
spontaneous release dynamics through just four parameters (kF1,
kF2, ti_sep, median duration). We fix ti_sep in simulations such that
only the width of the initiation time distribution (kF1, kF2) and
the median of the duration distribution are varied: ti distribution
widths of 350, 550, and 1,000 ms (Figure 3Ac) were used in tissue
simulations; duration medians of 150, 200, 250, 300, and 350
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ms (Figure 3Bd) were used in single-cell and tissue simulations.
Derivation of these equations from the fully detailed spatial cell
model ensures self-consistency and physiological validity of the
resulting waveforms.
Computational Aspects
Models were coded in C/C++ and run on a Linux desktop
machine, or using the University of Leeds ARC2 High
Performance Computing facilities. Equations for isolated cell
models were solved using a forward Euler method with a time
step of 1t = 0.05 ms; ion channel gating equations were solved
using the Rush-Larsen scheme (Rush and Larsen, 1978). For
tissue models, the monodomain equation was solved using a
Forward Time Centred Space method: Space steps of 1x =
0.2mm were used in the 1D strand, 1x = 1y = 0.2mm in
the 2D tissue, and 1x = 1y = 0.425mm and 1z = 0.5mm
in the 3D wedge model (as defined by the diffusion tensor
MRI dataset). Parallelisation was implemented with OpenMP.
Cell APD was measured from the time the membrane potential
crossed −80 mV during the upstroke of the action potential, to
when the membrane potential crossed back over−80 mV during
the repolarisation phase.
RESULTS
The hERG Activator MC-II-157c Partially or
Fully Reverses APD Prolongation
Heterogeneously
The single cell model was paced at a cycle length of 1,000
ms for 100 beats under control (WT), PQT and PQT + MC-
II-157c conditions to evaluate the efficacy of MC-II-157c on
reversing PQT induced APD prolongation (Figure 4). Figure 4A
shows effects on AP morphology of the PQTa, PQTb, and
PQTc conditions in endocardial, midmyocardial, and epicardial
cells, with WT action potentials shown as a reference. The
PQTb condition (downregulation of IKr) has the largest effect
on prolonging APD (from 360 to 649 ms in midmyocardial
cells, an increase of 80%), due to the larger IKr conductance in
human cells relative to IKs conductance, and its primary role
in AP repolarisation. All three PQT conditions increase the
transmural difference in APD (the difference between the longest
and shortest APDs in the three cell types), from 88 ms in WT to
97, 279 and 122 ms with PQTa, PQTb, and PQTc, respectively.
Figure 4B shows how the hERG activatorMC-II-157c reduces
APD back towards control levels in all cell types and with all PQT
conditions. The drug reduced APD back to control levels in PQTa
(downregulation of IKs) due to the minimal effect this condition
has on initially prolonging APD, but the largest decrease was
seen with PQTb in midmyocardial cells, where APD was reduced
from 649 to 540 ms, a reduction of 17% (Figure 4C). It should be
noted, however, thatMC-II-157c has transmurally heterogeneous
effects; that is, the degree of APD reduction seen in the three
different cell types is not identical, with the drug under PQTb
conditions (for example) giving a 5% decrease in endocardial
cells, 17% in midmyocardial cells and 4% in epicardial cells.
Consequently, the maximal transmural difference in APD in
PQTb reduces from 279 ms with the PQT condition alone to 184
ms with PQTb plus MC-II-157c, but does not reduce transmural
difference in APD back down to WT levels (184 vs. 88 ms).
ECGs were computed for the different conditions using the
3D ventricular wedge model under normal pacing (BCL = 1,000
ms). QT-prolongation was observed for all three remodeling
types (Figure 4C), with PQTb exhibiting the longest QT-interval,
congruent with single cell results (QT= 310ms inWT compared
to 326, 418, and 329 ms in PQTa-c, respectively). MC-II-157c
resulted in a delay in the QRS peak as well as earlier absolute
repolarisation time and consequent shortening of the QT interval
(QT = 309 ms, 403 and 310 ms in PQTa-c + MC-II-157c;
Figure 4C); in PQTa and PQTc, MC-II-157c fully reverses QT
prolongation.
The mechanism by which MC-II-157c shortens APD, despire
reducing the maximal conductance of IKr, is illustrated in
Figure 5: the shifts in the activation and inactivation curves and
the slowing of deactivation kinetics result in an increased current
during both voltage clamp and AP clamp experiments. These
results are generally congruent with the original study of Guo
et al. (2014), although the current traces do differ in morphology
and extent of effect of MC-II-157c (see Limitations).
MC-II-157c has PQT-Type Dependent
Effectiveness in Reversing SR Loading and
Spontaneous Release Events
The vulnerability to the emergence of whole-cell spontaneous
Ca2+ release events (such as intracellular Ca2+ waves, Figure 6A)
is primarily controlled by the dynamics of the intracellular
Ca2+ handling system and the SR Ca2+ load, wherein cells
typically exhibit an SR load threshold above which the probability
of spontaneous release events significantly increases (Wagner
et al., 2015). The focus of this study is not on the mechanisms
of spontaneous Ca2+ release, and therefore investigation of
Ca2+ handling remodeling is beyond its scope. However, APD
prolongation associated with PQT, and its subsequent reversal
by MC-II-157c, may influence SR loading and consequently the
vulnerability to the emergence of whole-cell spontaneous Ca2+
release.
An SR-loading protocol was used to analyse this behavior,
by pacing the spatial cell model at a rapid rate (cycle length
of 400 ms). The maximal flux rate of intracellular uptake was
increased, simulating the effect of sympathetic stimulation, in
order to promote SR loading. An increase by a factor of two
was chosen as this loaded the SR-Ca2+ in the WT model to just
above the spontaneous release threshold; the most suitable region
to reveal the consequence of APD modulation on spontaneous
activity.
The time series of SR-Ca2+ in WT and the PQTc condition in
isolated epicardial cells illustrates the effect on SR-Ca2+ loading
under rapid pacing and highlights that APD prolongation
associated with PQT can promote loading (Figure 6B). The
peak of the SR Ca2+ concentration during this time provides a
measure of SR Ca2+ loading; these data are shown in Figure 6C
for WT and all PQT conditions with and without MC-II-157c.
The PQTa condition (downregulation of IKs) does not promote
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FIGURE 4 | Action potential and ECG morphology and duration in PQT and MC-II-157c. (A) Action potentials for the three cell types (ENDO, left; M, middle; EPI, right)
under baseline (upper) and MC-II-157c (lower) conditions in control (WT, purple) and PQTa-c conditions (blue, green, red) in the spatial cell model. (B) Action potential
duration at −80 mV for the same conditions in (A). The colors in the key apply to both panels (A,B). (C) Computed ECGs for the three conditions (dotted red line) and
with the application of MC-II-157c (black line), relative to the WT (purple line). MC-II-157c was modeled as IKr modification + 40% INa block. Any impact of INa block
on the upstroke velocity is not clear at this scale.
SR loading compared to WT (peak SR Ca2+ load of 1.07mM
in WT and 1.06mM in PQTa), but the PQTb (downregulation
of IKr) and PQTc (upregulation of ICa,L) conditions do (peak SR
Ca2+ load of 1.106 and 1.13mM, respectively), with PQTc having
the largest effect due to the increase in the transmembrane Ca2+
current in this condition. MC-II-157c reverses SR Ca2+ loading
in PQTb, reducing peak SR Ca2+ load at periodic steady-state
to 1.05mM, which is below WT levels. However, the drug has
only a very small effect in PQTc (down to 1.108mM) due to the
minimal effect MC-II-157c has on APD in this condition, and the
subsequently small change in the time course of ICa,L.
These relatively small changes in SR-Ca2+ can manifest as
significant differences in the vulnerability to spontaneous Ca2+
release due to the non-linear threshold dependence on SR
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FIGURE 5 | Activity of IKr during voltage and AP clamp conditions under the application of MC-II-157c. IKr traces (b) elicited by a voltage step protocol (a) in
simulation (A) and experiments of Guo et al. (2014); (B) and elicited by a simulated AP clamp (C), for baseline (purple) and MC-II-157c (red) conditions. In (B), the
current traces have been normalized to the peak of the control current. Conditions in (A) were matched to those experimentally—the intracellular and extracellular
concentrations of potassium were set to 120 and 5.4mM, respectively.
Ca2+ concentration (Figures 6D,E). The probability of whole-
cell spontaneous release events and the probability distributions
describing the initiation time can be computed from a large set
of simulations (N = 1,000 per condition). Example distributions
are shown in Figure 6E for the WT and PQTc with and without
MC-II-157c, highlighting that even the small change in SR Ca2+
as a result of MC-II-157c significantly reduces the probability of
spontaneous release (∼50% in PQTc with MC-II-157c compared
to 98% in PQTc alone) as well as widening the distribution
(although not fully reversed toWT). Due to the choice of loading
parameters giving the WT close to threshold, no spontaneous
release occurs for either PQTa or PQTb under the application
of MC-II-157c as in these conditions threshold SR Ca2+ is not
reached.
MC-II-157c Is Effective in Inhibiting DADs
Turning into Triggered Activity
The effect of MC-II-157c on the probability of DADs manifesting
as full triggered action potentials was investigated using the
simplified, non-spatial model such that spontaneous release
waveforms could be directly controlled. The initiation time was
set to 1,000 ms and behavior of the cell models for WT, PQT
and PQT+MC-II-157c was compared over multiple simulations
(N = 1,000 per condition) for four different RyR waveform
duration distributions (see details in Simulating Spontaneous
Release Events in Tissue Models; the distribution determines the
values of duration which can be selected from a random number
input and thus the actual value of the duration will vary randomly
within the 1,000 simulations according to the given distribution).
Examples of 100 simulations for WT and PQTb, with and
without MC-II-157c, are shown in Figure 7A. In PQTb, more
DADs turn into triggered activity compared to in WT (top two
panels), while simulated application of MC-II-157c reduces the
occurances of triggered activity (bottom two panels). These data
are summarized for all conditions and two duration distributions
(median 300 and 350 ms, see Simulating Spontaneous Release
Events in Tissue Models) in Figure 7B, wherein the degree of
block of INa associated with MC-II-157c is varied (0, 40, and 80%
block). In all cases, the IKr modification reduces the probability of
triggered activity (defined as the number of simulations in which
triggered activity occurred as a proportion of the total), but the
role of INa is less clear; blocking INa is important, but the degree
of INa block has different effects depending on the condition.
The mechanism of the drug’s action is shown in Figure 7C:
principally, an increase in repolarising IKr acts during the DAD
to keep the cell’s membrane potential below the threshold for
triggered activity; reduced INa also pays a role (although not as
great as that of IKr) in the drug’s mechanism of action as it reduces
excitability of the cell, again reducing the ease with which the
cell’s membrane potential can reach threshold.
MC-II-157c Reduces Vulnerability to
Ectopic Activity in Tissue
The vulnerability to the development of ectopic activity (i.e.,
propagation of triggered activity in all directions through
the tissue) was assessed in a 2D homogeneous sheet to
provide a medium for the synchronization of independent
stochastic release events. Ten simulations were performed for
each condition (WT and PQT variants ± MC-II-157c for the
combinations of ti and duration median distributions; Epicardial
cell model) wherein the tissue model was paced to steady state
and then left quiescent for two simulation seconds within which
time the spontaneous release occurs.
The occurrence of ectopic activity exhibits a largely “all-
or-nothing” response, where most conditions lead to either 0
or 100% of simulations resulting in a premature excitation
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FIGURE 6 | SR Ca2+ loading and spontaneous Ca2+ release events. (A) Example of a whole-cell spontaneous Ca2+ release event (Ca2+-wave), using the spatial
model of stochastic intracellular Ca2+ handling, showing the Ca2+ transient (upper) and snapshots of Ca2+ concentration in the 3D cell volume (lower). The triangular
makers in the upper panel indicate the timings of the snapshots in the lower panel. (B) Time-series of SR-Ca2+ during the SR-loading protocol, shown for control
(WT, purple) and PQTc (red). (C) Peak SR-Ca2+ during the loading protocol for all conditions. (D) Examples of spontaneous release resulting from SR-loading for
control (WT, purple), PQTc (red) and PQTc + MC-II-157c (orange). 100 simulations of each conditions are shown to indicate variation in spontaneous release. (E)
Distributions of initiation time of spontaneous release events, corresponding to the same conditions shown in (D). The time is relative to the start of the simulation
(3 beats, initial conditions of dynamic steady state) to align with (D). MC-II-157c was modeled as IKr modification + 40% INa block.
(Table 1). Ectopic activity was promoted by narrow distributions
of initiation time (i.e., tight synchronization) and short RyR
waveforms (i.e., large spontaneous Ca2+ transients), and
conversely inhibited by wide distributions of initiation time
(i.e., lose synchronization) and long RyR waveforms (i.e., small
spontaneous Ca2+ transients). For example, no ectopic activity
was observed for any condition with ti distribution widths of
1,000 ms or duration medians of 300 ms or longer, whereas a ti
distribution width of 350 ms combined with median durations of
150 or 200 ms resulted in ectopic activity occurring in 100% of
simulations (Table 1).
PQT variants were more susceptible to the development of
ectopic activity in tissue than WT, congruent with the single-cell
results (See MC-II-157c Is Effective in Inhibiting DADs Turning
into Triggered Activity). Similarly in-line with single-cell results,
MC-II-157c can inhibit ectopic activity (Table 1): for example,
it reduces or entirely inhibits the occurrence of premature
excitation in four conditions: PQTa with ti width of 550ms
and duration median 150 ms; PQTc with ti width of 550 ms
and duration median 200 ms; PQTc with ti width of 550ms
and duration median 150 ms; and PQTc with ti width of
350ms and duration median 250 ms. The effect of INa block
is also congruent with single cell results: it contributes to the
inhibition of ectopic activity, but to a smaller extent than IKr
modification.
Figure 8A shows an example of synchronized triggered
activity initiating in a region of the 2D tissue (shown by the
clustered peaks the images), before this triggered activity spreads
throughout the tissue (shown by the yellow region) as an
ectopic propagation. When the same situation is simulated with
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FIGURE 7 | Development of triggered action potentials in single cell. (A) 100 Action Potential traces for control (WT, left) and PQTb (right) under baseline (upper) and
MC-II-157c (lower) conditions, associated with spontaneous Ca2+ release events. A proportion of the DADs manifest as triggered action potentials in all conditions.
(B) Probability of DADs triggering full action potentials for control (WT) and PQTa-c under baseline and MC-II-157c conditions. The degree of INa block associated with
MC-II-157c is varied between 0% (IKr only), 40 and 80%. The upper panel corresponds to a median RyR waveform duration of 350ms; the lower panel to 300ms. (C)
Illustration of the mechanism by which MC-II-157c inhibits triggered activity, showing that the larger IKr (lower panel and inset) acts to oppose depolarising currents
during the DAD. Yellow highlighted region clearly illustrates the differences between the conditions.
MC-II-157c (Figure 8B), triggered activity, and therefore ectopic
propagation, is inhibited.
MC-II-157c Increases the Vulnerable
Window in Tissue
An S1-S2 pacing protocol was applied to the 1D strand model
in order to compute the vulnerability window: S2 stimuli were
applied across a range of time intervals, centered on one in every
five cells of the 100 comprising the model, from the tenth to the
90th.
Examples of propagation applied during the repolarisation
phase in 1D tissue simulations are shown in Figure 9A: if the
triggered activity occurs early (at 311 ms in this example), the
resultant excitation is surrounded by refractory tissue and the
triggered activity dies out without propagating; If the triggered
activity occurs slightly later (e.g., 316 ms) then refractory tissue
is encountered at only one side of the triggered activity site
and unidirectional block (or unidirectional propagation) occurs,
in the retrograde direction (back toward the endocardium) in
this example; If triggered activity occurs later than this (321
ms in this example) then all surrounding tissue has recovered
and the triggered activity propagates in both directions along
the strand (i.e., ectopic propagation, analogous to the situation
shown in 2D tissue in Figure 8A). It is the unidirectional
block situation (i.e., when the triggered activity occurs in the
VW) that can lead to re-entrant arrhythmias if this situation
occurred in 2D or 3D tissue. The VW identifies occurrences of
trigger and substrate interaction that may lead to arrhythmias,
and so quantifying the size VW is a convenient method to
examine effects of disease conditions and drugs on trigger and
substrate interaction. The baseline VWs for WT and the PQTa
condition are mapped out in Figure 9B, as well as VWs in
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TABLE 1 | Incidence of ectopic activity in 2D tissue under WT and PQT ± MC-II-157c conditions.
ti width 1,000 550 350
Duration median 300 250 200 150 300 250 200 150 300 250 200 150
WT 0 0 0 0 0 0 0 0 0 0 10 10
PQTa 0 0 0 0 0 0 0 10 0 0 10 10
PQTa+C 0 0 0 0 0 0 0 0 0 0 10 10
PQTa+CNa 0 0 0 0 0 0 0 0 0 0 10 10
PQTb 0 0 0 0 0 0 10 10 0 10 10 10
PQTb+C 0 0 0 0 0 0 10 10 0 10 10 10
PQTb+CNa 0 0 0 0 0 0 10 10 0 10 10 10
PQTc 0 0 0 0 0 0 10 10 0 10 10 10
PQTc+C 0 0 0 0 0 0 6 5 0 9 10 10
PQTc+CNa 0 0 0 0 0 0 0 0 0 1 10 10
The number of simulations where a premature excitation was observed is shown for each condition (out of a total of 10). The compound MC-II-157c is denoted by a “C” with IKr
modification alone and “CNa” with inclusion of 40% block of INa. Highlighted with red borders are the conditions in which MC-II-157c inhibits the development of ectopic activity.
FIGURE 8 | Development of premature excitation in 2D tissue sheets. Temporal snapshots of the membrane voltage in a 2D slice of tissue during spontaneous Ca2+
release events for PQTa (A) and PQTa + MC-II-157c (IKr modification + 40% INa block, (B). The color bar has been scaled to emphasize voltage differences in the
DAD region and lighting has been added to further enhance local variation in voltage. Data corresponds to ti width of 550 ms and duration median 150 ms.
these two situations with simulated addition of MC-II-157c (IKr
modification plus 50% INa block), as well as with only the MC-
II-157c IKr modification. These VWs are quantified by length
(over which they occur in the 1D strand) and area (length ×
temporal width). In both WT and PQTa conditions, the drug
increases both the length and the area of the VW (for example,
length increases from 9 to 16mm in the PQTa condition, and
area increases from 78 to 101mm.ms). Again, the influence of
INa is different depending on the condition: including the effects
of INa (i.e., the full MC-II-157c simulations compared to the
IKr only simulations) increases the length of tissue over which
the VW occurs in all conditions (e.g., from 12 to 16mm in
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FIGURE 9 | Vulnerability windows to unidirectional conduction block. (A) Examples of propagation following applied S2 stimulus at different time intervals, illustrating
conduction block (left), unidirectional conduction (middle) and full conduction (right). (B) Vulnerability windows for control (WT, upper) and PQTa (lower) under baseline,
MC-II-157c (IKr modification + 40% INa block) and IKr modulation alone conditions. The lower line in each plot represents the refractory period (time below which no
propagation occurs); the upper line represents the earliest time of bidirectional conduction; the area between the lines (shaded yellow) is the region within which
unidirectional conduction occurs. Right panel is bar charts summarizing the length (mm) and area (mm.ms) of the vulnerability windows. Dotted lines illustrate the
regions of the different cell types (ENDO, left; EPI, right).
PQTa), but reduces the overall area of the VW (e.g., from 126
to 101mm.ms).
DISCUSSION
We used a multi-scale computational modeling approach to
examine the interactions between cardiac arrhythmia trigger
and substrate in general conditions associated with prolonged
QT intervals, and their modulation by the hERG activator and
sodium channel blocker MC-II-157c. Although we examined the
effects of pharmacological modification on trigger and substrate
interaction using a specific hERG activator, and gained novel
insights into how modification of the depolarising (INa) and
repolarising (IKr) membrane ionic currents targeted by the
drug affects arrhythmia triggers and substrates, our findings
also provide general insight into the role of ion-currents in
controlling triggers and substrate at multiple scales which, along
with insight from other in silico studies [see (Dutta et al., 2016;
Mann et al., 2016) for recent examples], may be applicable to
other pharmacological compounds that modify membrane ionic
currents as well as pro-arrhythmic electrical remodeling.
Key Findings
Our key findings are that: (i) Despite the hERG activator MC-II-
157c reducing the maximal conductance of IKr by 12% compared
toWT, the drug’s modifications to IKr activation, inactivation and
deactivation kinetics result in an overall increase in IKr during
the action potential, and a concomitantly reduced APD under
all PQT conditions in all transmural cell types; (ii) Although
MC-II-157c acts on membrane ionic currents carrying K+ and
Na+, the drug has indirect effects on intracellular Ca2+ handling,
particularly SR Ca2+ loading and related spontaneous SR Ca2+
release events and subsequent DADs, through modulation of
the AP; (iii) Increased IKr (through its repolarising effects) and
reduced INa (by decreasing cell excitability) act to reduce the
probability of a DAD reaching threshold and developing into
triggered activity at both cellular and tissue scales; and (iv)
Despite MC-II-157c reducing triggered activity at the cell level,
the drug can increase both the spatial region of tissue over which
a VW for unidirectional conduction block occurs, as well as
the temporal width of the VW at all points along the tissue,
and in doing so increases the total spatiotemporal size of the
VW. These results highlight the complex considerations which
underlie overall vulnerability to arrhythmia at multiple scales.
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Efficacy of MC-II-157c as an
Anti-Arrhythmic Drug
At the isolated cell level, MC-II-157c reduces SR Ca2+ loading,
reduces the occurrences of spontaneous SR Ca2+ release events,
reduces DAD occurrences, and reduces the probability of a DAD
developing into a triggered action potential. At the tissue level,
the combination of these factors leads to a significantly reduced
vulnerability to the development of ectopic beats; MC-II-157c
reduces the probability of an ectopic beat development at given
spontaneous release function distributions (i.e., synchronization
degree) as well as inhibiting SR Ca2+ loading and thus reducing
synchronization (which, itself, reduces the probability of ectopic
beats). In relation to the development of Ca2+ induced triggers
at single cell and tissue levels, therefore, our simulation results
suggest that the drug has efficacy as an anti-arrhythmic.
However, even though arrhythmic triggered activity is
reduced with the drug, the spatiotemporal area of the VW
increased, and so the anti-arrhythmic effects of the reduced
probability of an arrhythmia trigger occurring is opposed
by the pro-arrhythmic effects of an increased arrhythmia
substrate. This highlights the importance of examining the
effects of pharmacological compounds on both the triggers
and the substrates that underlie arrhythmia initiation: there
is a delicate balance between increased/decreased trigger
and increased/decreased substrate (i.e., trigger-substrate
interaction) that determines whether any given trigger stimulus
(e.g., a spontaneous SR Ca2+ release event) will result in
unidirectional propagation and, potentially, initiation of a re-
entrant arrhythmia. This is one potential reason that single cell
studies showing efficacious effects of putative anti-arrhythmic
drugs may not translate to the clinic.
The effects of MC-II-157c on the VW occur through two
mechanisms due to the drug’s action on both IKr and INa, both of
whichmodify transmural dispersion of repolarisation. Activation
of IKr causes heterogeneous changes to APD at the tissue level, the
same mechanism as in our previous studies examining the effects
of NS1643 (Peitersen et al., 2008). Block of INa results in slowed
transmural conduction (Kléber and Rudy, 2004) and therefore
delayed activation of epicardial (but not endocardial) tissue: this
in turn modifies transmural dispersion of repolarisation, even
though the change to APD isminimal with INa block. Block of INa
also reduces excitability of the tissue, necessitating a larger trigger
to initiate propagation, which also contributes to the change in
the VW.
Varying Effects of Sodium Current Block
The role of INa loss of function in arrhythmogenesis has been
examined in detail previously (see Clancy et al., 2015 for a
review); however, one intriguing finding from our cell and tissue
simulations was the varying effects that different magnitudes of
INa block had on trigger development and substrate size. At
the cell level, the probability of triggered activity developing
from DADs did not follow a simple monotonic change with
increasing INa block in all cases. Take, for example, the 350 ms
Ca2+ release duration distribution results shown in the top panels
of Figure 7B: In WT and the PQTb condition, INa block (in
addition to the IKr modification) reduces the probability of DADs
developing into triggered activity (relative to the IKr modification
alone), with more block reducing this probability; that is to say,
the greater the INa block, the more anti-arrhythmic (in terms of
reducing triggered activity) the effects. However, in the PQTa
condition, while 40% block of INa reduced the probability of
triggered activity occurring, increasing block of the current to
80% slightly increased the probability of triggered activity; in
this condition, a small amount of INa block has anti-arrhythmic
effects, but increasing this small level of block is pro-arrhythmic.
In the PQTc condition, INa block of any magnitude increased the
probability of triggered activity (i.e., INa block is pro-arrhythmic),
with the probability of triggered activity occurring increasing as
INa block is increased. Similarly varied results were found for
the 300 ms Ca2+ release duration distribution (lower panels in
Figure 7B), although the anti-/pro-arrhythmic effects did not
necessarily match those seen with the 350 ms distribution.
One further note of caution with regards to INa block comes
from our tissue-level VW results in Figure 9B. Quantification of
the length of tissue over which the VWoccurs shows that 50% INa
block (compare the full MC-II-157c effects to the effects with the
IKr modification alone) increases this length, potentially due to
an increase in transmural dispersion of repolarisation with INa
block; analyses of these results alone would conclude that INa
block is pro-arrhythmic. However, despite the spatial width of the
VW increasing, block of INa results in the total spatiotemporal
area of the VW decreasing (again, compare the full MC-II-157c
effects to the effects with the IKr modification alone), i.e., an
anti-arrhythmic result, likely due to the reduced excitability that
results from INa block reducing the likelihood that any triggered
activity would propagate.
Our tissue-level findings therefore indicate that INa block per
se is an effective antiarrhythmic strategy (as seen with class I
antiarrhythmic drugs; Camm, 2012), but our cell-level findings
highlight that the magnitude of INa determines cell (and by
extension, tissue) electrophysiological consequences in a manner
that is not intuitive. The mechanisms underlying these varying
effects of INa block on arrhythmogenesis, particularly on DAD
initiation and their development into triggered activity, remain
to be elucidated.
Modifying Abnormal Intracellular Calcium
Handling through Membrane Current
Modification
Although this study did not focus on the mechanisms of
arrhythmia triggers (in that we prescribed SR Ca2+ release events
under certain conditions), one interesting finding did emerge in
relation to arrhythmia triggers that can result from abnormal
intracellular Ca2+ handling: Modification of membrane ion
channels carrying ions other than Ca2+ (K+ and Na+ in this
case) can have beneficial effects in terms of restoring abnormal
intracellular Ca2+ handling, through their actions in shortening
APD. This was shown in Figure 6, where the increased SR Ca2+
loading (and resultant spontaneous SR Ca2+ release events)
seen under PQT conditions was reversed by upregulating IKr
and downregulating INa, which in turn shortened APD. This
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reduces the duration over which ICa,L is activated, reduces the
amount of Ca2+ crossing the cell membrane and entering the cell
via that current, and thus reduces SR Ca2+ load. Furthermore,
the combined action of both of these current modifications
reduced the probability of DADs manifesting as triggered action
potentials in single cell as well as triggered action potentials
manifesting as fully propagating ectopic beats at the tissue scale.
Targeting cell membrane ion channels carrying ions other than
Ca2+ in order to restore abnormal intracellular Ca2+ handling
(as seen in heart failure, for example; Lou et al., 2012) may
be beneficial in cases where up/downregulation of Ca2+-specific
drug targets (ryanodine receptors or SERCA, for example) will
alter the delicate homeostasis of an already-compromised system,
yielding negative results (Ratner, 2015).
Development of Arrhythmic Conduction
Patterns
One-dimensional models (other than 1D rings; e.g., Vinet and
Roberge, 1994) cannot simulate re-entrant activity, and so
it is necessary to use 2D and 3D models to examine how
unidirectional propagation develops into re-entry. Although the
quantitative characteristics of the VW examined in 1D tissues
may change in 2D and 3D depending on the spatial locations of
cell types (e.g., “base-apex” as well as transmural distributions),
based on our previous work we would expect the qualitative
characteristics to remain similar (Benson et al., 2007, 2008,
2011a). We show examples of 2D and 3D modeling in Figure 10:
In Figure 10A, a trigger occurring in the VW (resulting in
unidirectional conduction block) develops into re-entry in a
simple 2D model; In Figure 10B, a trigger occurring outside
the VW develops into ectopic propagation (i.e., not re-entrant)
in a detailed 3D model of a human left ventricular wall slab,
which manifests as significant differences in the body surface
potential activation maps (Figure 10C). The advantages of using
detailed 3D models (in this case, where the geometry is obtained
from diffusion tensor MRI) lie in their ability to reproduce
the orthotropic conduction velocities resulting from complicated
tissue architecture (i.e., fiber and sheet structure; Benson et al.,
2007; Smaill et al., 2013) and the boundary and curvature
effects that can modulate electrotonic coupling and propagation
(Walton et al., 2013; Campos et al., 2015): these effects are
crucial in understanding the complex and chaotic propagation
patterns underlying cardiac arrhythmias. Nevertheless, the 1D
models used in this study allow us to examine arrhythmia trigger-
substrate interaction in a simple and methodological manner.
Limitations
In this study, a general model of intracellular Ca2+ handling
was integrated with a simplified formulation of a human
ventricular AP model. Due to the general nature of the Ca2+
handling model, details of heterogeneity in Ca2+ handling
were not included in order to avoid introducing artifacts.
For this reason, and due to the multi-scale focus of the
study, detailed investigation of the mechanisms of spontaneous
release in single cell, and their regional dependencies, was
not performed, and investigation was instead limited to the
potential effect of MC-II-157c on reversing SR Ca2+ loading.
There are many possible mechanisms of spontaneous release
associated with diseases linked to prolonged QT interval (e.g.,
hyper phosphorylation of the RyRs; upregulation of SERCA;
detubulation) which were not considered in the present study.
However, the aim of this study was to investigate the multi-
scale interaction between trigger and substrate, and the use
of the simplified spontaneous release functions in single-cell
and tissue simulations allowed this to be analyzed in a general
manner and across a large range of conditions, independent of
spontaneous release mechanism. In future, combining detailed
single cell studies of the mechanisms of spontaneous release in
disease conditions with tissue simulations of the same conditions
would provide further mechanistic insight; a dynamic simplified
spontaneous release model would furthermore allow the study
of long-term interactions between trigger and substrate in tissue
e.g., during re-entry.
The factors underlying the synchronization and propagation
of ectopic activity are highly complex and it is therefore
worth making explicit that our simplified approach (which does
not consider, for example, heterogeneity in the distributions
describing Ca2+ release) is primarily suitable for interpretation
of general trends only, rather than as a quantitative analysis of
the efficacy ofMC-II-157c inmodulating Ca2+ release dependent
triggers; it is encouraging to note that our results are consistent
with those of a previous study (Campos et al., 2015), with the
emergence of premature excitation from independent stochastic
events overcoming electrotonic load, and the steep, “all-or-
nothing” relationship observed in tissue. This steep relationship
also likely accounts for the lack of effect of MC-II-157c on
PQTb (the condition exhibiting the highest vulnerability to
ectopic activity), wherein the distributions selected were not close
enough to the threshold region to reveal an effect.
The relative contribution of IKr to repolarisation is different
in different models of the human ventricular action potential
(Mirams et al., 2014): for example, IKr contributes more
repolarising current in the ORd model (O’Hara et al., 2011) than
in the ten Tusscher & Panfilov model (ten Tusscher and Panfilov,
2006), despite both models being validated against experimental
data. It is therefore possible that our results overestimate the
effects of the hERG activator MC-II-157c, although the identified
pro- and anti-arrhythmic mechanisms will still be relevant.
The limitations of using 1D and 2D simplifications of 3D
cardiac tissue have been discussed in detail previously (Clayton
et al., 2011). Here we only note that the 1D strand model of the
left ventricular wall allows us to examine mechanisms underlying
how arrhythmia triggers and substrates interact to initiate
unidirectional propagation, without the added complicating
effects that geometrical (shape) and architectural (fiber, sheet etc.)
considerations would bring. Nevertheless, it is anticipated that
these geometrical and architectural effects will play a role not only
in the transition from unidirectional propagation to re-entry, but
on the initiation of the unidirectional propagation itself through,
for example, electrotonic effects (Benson et al., 2007; Walton
et al., 2013). Similarly, our 2D and 3D tissues were isotropic,
i.e., no fiber or sheet structure, and so any conclusions drawn
from these simulations should be interpreted with this in mind.
Elucidating the roles that tissue geometry and architecture play in
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FIGURE 10 | Examples of abnormal electrical excitation. (A) Example of conduction block in a 2D sheet, analogous to that observed in the 1D strand for computation
of the vulnerability windows. Three snapshots in time are shown to illustrate the potential of unidirectional conduction block to develop into asymmetric, re-entrant-like
activity. (B) Propagation patterns in the 3D ventricular wedge, showing normal, control pacing (upper panel) and a spontaneous ectopic beat (lower panel). The
propagation of DADs, preceding the ectopic beat, is clear by the purple colored regions in the lower center panel. The voltage color bar corresponds to both panels
(A,B). (C) Body-surface potential activation maps (time at which potential > 0.1 mV) associated with normal and ectopic propagation, highlighting the significant
difference in spatial patterns between the two conditions.
arrhythmogenesis (Smaill et al., 2013) is an important next step in
fully understanding arrhythmia trigger and substrate interaction.
The spatial distributions of endocardial, midmyocardial,
and epicardial cell types across the human ventricular wall
has still not been confirmed: some studies suggest that
midmyocardial cells are found predominantly in isolated regions
of the subendocardium (Glukhov et al., 2010), while others
suggest a continuous population of midmyocardial cells in the
subepicardial region (Drouin et al., 1995); these distributionsmay
be dependent on species, location in the ventricular wall, and
disease state (Antzelevitch, 2010; Strom et al., 2010). Because of
this uncertainty, we set the spatial distribution of the three cell
types to be equal in the transmural direction, but the effects of
the electrotonic interactions of different regions of cell types are
likely to be qualitatively similar if these distributions are altered.
The simulated model of MC-II-157c reproduced qualitatively
the key features of the effect of the compound on IKr (i.e.,
an increased activity during a depolarising pulse), but it is
important to note that there were significant differences between
the simulation and experimental data (Figure 5): firstly, the
formulation of IKr implemented does not have a time-dependent
inactivation, which is observed in the experimental trace;
secondly, the simulated data exhibited a larger difference in the
magnitude of the current during the depolarisation step between
baseline and MC-II-157c than observed experimentally. A more
detailed model of IKr in both basal and MC-II-157c conditions
would be essential for future and more detailed analysis of the
compound specifically.
Furthermore, recent work, (e.g., Li et al., 2017), has
highlighted that simple modulation of Hodgkin-Huxley current
formulations, as used to simulate IKr in the ORd model, may not
sufficiently capture complex drug-channel interaction dynamics,
and that more complex Markov model formulations may be
necessary to simulate such dynamics. However, until a full
experimental characterisation of the dynamics of MC-II-157c
effects on IKr under a range of conditions is carried out, allowing
a validated Markov model of drug-channel interactions to be
developed, we make use of the available data (Guo et al.,
2014) to modify the Hodgkin-Huxley formulation used in the
ORd model. The effects of MC-II-157c on INa are not as well
characterized as its effects on IKr (Guo et al., 2014). We simulated
the drug’s action on INa by a simple reduction in the maximal
conductance of the current. It is possible, however, that MC-II-
157c alsomodifies the current’s kinetics (i.e., shifts to the current’s
activation and inactivation curves, and/or a change to the time
constants associated with these processes) in a similar manner to
the way in which the kinetics of IKr are modified. Thus, further
experimental characterisation of the drug’s effects on both IKr and
INa are required.
CONCLUSION
The relative balance of reduced trigger and increased substrate
underlies a multi-dimensional role of MC-II-157c in modulation
of arrhythmia vulnerability associated with prolonged QT
interval. Our results highlight that studies examining the efficacy
of putative anti-arrhythmic drugs need to assess the effects of
the drug on both the triggers and the substrates involved in
arrhythmogenesis, i.e., such studies should adopt a multiscale
approach to examine both cell- and tissue-level effects.
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